Hepatosplenic T-cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of malignant T-cells primarily affecting the liver and spleen. It often arises in immunocompromised individuals, particularly those with a history of chronic infections or autoimmune diseases. Accurate coding with ICD-10 Code C86.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C86.1 specifically designates Hepatosplenic T-cell lymphoma, a subtype of peripheral T-cell lymphoma. This code should be used when documenting cases of this malignancy, which is often associated with immunosuppression and can lead to significant morbidity. It is crucial for accurate clinical documentation and billing, ensuring that healthcare providers can track and manage the disease effectively.
Hepatosplenic T-cell lymphoma is primarily caused by the uncontrolled proliferation of T-lymphocytes, often linked to underlying immunosuppression. The condition can progress rapidly, leading to severe complications such as liver failure and systemic symptoms. Prompt medical attention is necessary to manage this aggressive lymphoma effectively.
In SOAP notes, ICD-10 Code C86.1 is utilized to document the diagnosis of Hepatosplenic T-cell lymphoma, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
ICD-10 Code C86.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Hepatosplenic T-cell lymphoma. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Hepatosplenic T-cell lymphoma often necessitates urgent medical intervention, including hospitalization for intensive treatment. Standard approaches focus on chemotherapy and may involve targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.1 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance |
| 99223 | Initial hospital care, typically 70 minutes or more |
| 36415 | Collection of venous blood by venipuncture |
| 85025 | Complete blood count with automated differential white blood cell count |
Common Questions About Using ICD-10 Code C86.1 for Hepatosplenic T-cell lymphoma
What are the common symptoms of Hepatosplenic T-cell lymphoma?
Common symptoms include fatigue, unexplained weight loss, fever, night sweats, and abdominal discomfort due to hepatosplenomegaly.
How is Hepatosplenic T-cell lymphoma diagnosed?
Diagnosis typically involves clinical evaluation, imaging studies, and biopsy to confirm the presence of malignant T-cells in the liver and spleen.
What treatment options are available for Hepatosplenic T-cell lymphoma?
Treatment often includes chemotherapy, targeted therapies, and supportive care to manage symptoms and complications associated with the disease.
Is Hepatosplenic T-cell lymphoma associated with any specific risk factors?
Yes, it is often associated with immunosuppression, including conditions like HIV, autoimmune diseases, and prior organ transplants.
Clinical Notes
SOAP notes
DAP notes
AI medical notes